Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Podcast: Dosage & Delivery Drive Innovation in the Joint Health & Anti-Inflammation Category - Nutraceuticals World

What are you searching for?

Sign in

Podcast: Dosage & Delivery Drive Innovation in the Joint Health & Anti-Inflammation Category

Gencor and Pharmako Biotechnologies highlight noteworthy delivery trends and ingredients.

By: Lisa Olivo

, Rodman Media

Consumers are seeking out convenient and enjoyable formulas to support joint health and inflammation. Powders, shakes, shots, and ready-to-drink mixes are popular delivery formats in the category, however leading ingredients offering support may not always be conducive to novel delivery systems. 
 
This dilemma led Pharmako Biotechnologies and its exclusive U.S. distributor and partner Gencor to develop innovative bioavailable formulas for the joint health and inflammation categories. In this interview, R.V. Venkatesh, managing director for Gencor, and Eric Meppem, director of Pharmako Biotechnologies, discuss the benefits of bioavailable HyrdoCurc curcumin, as well as Levagen and Levagen+ palmitoylethanolamide (PEA).

Keep up with the story. Subscribe to the Nutraceuticals World free daily
newsletter

Topics